Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 27.29 as of Wednesday, August 5, 2026.
Forward PE Ratio (27.29) = Close Price ($30.11) / Consensus Forward EPS ($1.10)
FORWARD PE RATIO
27.29
SECTOR MEDIAN · HEALTHCARE
19.59
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+39.31%
vs the sector median at left
Oscar Health, Inc.
Market Cap
$7.81B
Forward PE Ratio
27.29
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Oscar Health, Inc. (OSCR) | $7.81B | 27.29 |
| Tempus AI, Inc. (TEM)vs › | $8.18B | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | N/A |
| Insulet Corp. (PODD)vs › | $9.23B | 25.73 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.36B | 36.79 |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | N/A |
| Henry Schein, Inc. (HSIC)vs › | $10.21B | 16.66 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 7.65 |
| Universal Health Services, Inc. (UHS)vs › | $10.39B | 7.42 |
| Bio-Techne Corporation (TECH)vs › | $11.27B | 37.49 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
27.3
consensus next-FY EPS
At today's $30.11 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.10 | $-0.63 – $2.61 | 6 | 27.3x |
| 2027-12-31 | $1.56 | $0.05 – $2.58 | 6 | 19.3x |
| 2028-12-31 | $2.22 | $1.97 – $2.51 | 4 | 13.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
